Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Nov. 03, 2012		Oct. 29, 2011		Oct. 30, 2010
Cash flows from operating activities
Net earnings (loss)	$ 2,596	[1]	$ (21,067)	[2],[3]	$ (50,375)
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:
Depreciation and amortization	31,641	[4]	32,824	[4]	36,632	[4]
Stock-based compensation expense	6,476		2,255		3,107
Goodwill impairment	0		40,455		56,424
Other intangible and fixed asset impairments	0		0		13,674
Restructuring and exit costs	2,068		865		2,849
Loss (gain) on disposition of assets, net	209		232		(1,116)
Provision (benefit) for bad debt expense	1,290		(1,925)		8,111
Deferred taxes	1,349		(5,139)		(22,067)
Change in current assets and liabilities:
Trade receivables	4,237		(19,424)		(12,175)
Inventories	(14,181)		(11,374)		(16,467)
Prepaid expenses and other current assets	1,396		12,926		2,868
Accounts payable	1,021		13,668		24,283
Accrued liabilities	5,976		(3,091)		(5,837)
Other, net	195		1,093		(581)
Net cash provided by operating activities	44,273		42,298		39,330
Cash flows from investing activities
Capital expenditures	(19,967)		(29,072)		(21,432)
Proceeds from the disposition of assets	154		453		3,560
Net cash used by investing activities	(19,813)		(28,619)		(17,872)
Cash flows from financing activities
Bank credit facility borrowings (payments), net	2,725		(14,199)		45,900
Payments on notes and bank term loan	(24,705)		(378)		(87,582)
Payments on bonds and leases	(488)		(723)		(515)
Debt issuance costs	(1,660)		(1,558)		(1,174)
Stock-based compensation exercised	(107)		(295)		(194)
Net cash used by financing activities	(24,235)		(17,153)		(43,565)
Effect of exchange rate changes on cash and cash equivalents	(10)		(549)		82
Increase (decrease) in cash and cash equivalents	215		(4,023)		(22,025)
Cash and cash equivalents at beginning of year	877		4,900		26,925
Cash and cash equivalents at end of year	1,092		877		4,900
Cash paid during the year for:
Interest	10,920		10,208		12,780
Income taxes (refunded) paid	$ (345)		$ (11,350)		$ 5,711

[1] Operating earnings and net earnings from continuing operations in 2012 were impacted by charges totaling $8,834 ($5,917 net of tax), comprising merger and transaction costs of $6,901 ($4,486 net of tax), restructuring and exit costs of $2,521 ($1,866 net of tax), and foreign currency gains of $588 ($435 net of tax). Fourth quarter 2012 operating earnings and net earnings include foreign currency gains which pertain to prior annual periods of $1,465 ($1,026 net of tax). Prior annual periods were not corrected as such amounts were immaterial and thus recorded in the fourth quarter of 2012.

[2] The earnings from discontinued operations in 2011 include the settlement agreement for breach of contract by Chemtura that led to $4,844 in cash proceeds and after tax earnings of $3,003.

[3] Operating earnings and net earnings from continuing operations in the fourth quarter of 2011 were impacted by charges totaling $41,067 ($28,813 net of tax), comprising goodwill impairments of $40,455 ($28,435 net of tax), restructuring and exit costs of $634 ($393 net of tax), and foreign currency gains of $22 ($15 net of tax).

[4] Excludes discontinued operations.